Sía eftir: Last updated date SelectEftirFyrirFrom - To Date Lokadagsetning This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Niðurstöður (3828) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Call for expression of interest for independent scientific experts to participate in the work of EMA’s Safety Committee 3 nóvember 2023NewsHumanCorporateMedicines EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5 31 október 2023NewsHumanCOVID-19Vaccines EMA business hours over All Saints' Day and All Souls' Day, 1 and 2 November 30 október 2023NewsCorporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 October 2023 27 október 2023NewsHumanPharmacovigilanceReferrals EMA takes further steps to address critical shortages of medicines in the EU 24 október 2023NewsHumanMedicine shortages EMA alerts EU patients and healthcare professionals to reports of falsified Ozempic pens 18 október 2023NewsHumanMedicines New treatment option for heavily pre-treated multiple myeloma patients 13 október 2023NewsHumanMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 October 2023 13 október 2023NewsHumanMedicinesReferrals Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 September 2023 12 október 2023NewsVeterinaryMedicines Monitoring of products originating from Japan for the possibility of radioactivity 11 október 2023News 1 … 25 26 27 28 29 Page 29 of 383 30 31 32 33 … 383
Call for expression of interest for independent scientific experts to participate in the work of EMA’s Safety Committee 3 nóvember 2023NewsHumanCorporateMedicines
EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5 31 október 2023NewsHumanCOVID-19Vaccines
EMA business hours over All Saints' Day and All Souls' Day, 1 and 2 November 30 október 2023NewsCorporate
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 October 2023 27 október 2023NewsHumanPharmacovigilanceReferrals
EMA takes further steps to address critical shortages of medicines in the EU 24 október 2023NewsHumanMedicine shortages
EMA alerts EU patients and healthcare professionals to reports of falsified Ozempic pens 18 október 2023NewsHumanMedicines
New treatment option for heavily pre-treated multiple myeloma patients 13 október 2023NewsHumanMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 October 2023 13 október 2023NewsHumanMedicinesReferrals
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 5-7 September 2023 12 október 2023NewsVeterinaryMedicines
Monitoring of products originating from Japan for the possibility of radioactivity 11 október 2023News